标题
Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
作者
关键词
-
出版物
Cancers
Volume 13, Issue 18, Pages 4548
出版商
MDPI AG
发表日期
2021-09-10
DOI
10.3390/cancers13184548
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
- (2020) Ana Rita Pombo Antunes et al. eLife
- Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
- (2019) Thiago A. Patente et al. Frontiers in Immunology
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
- (2019) Kurt A. Schalper et al. NATURE MEDICINE
- Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) + radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM).
- (2019) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Survivin is a prognostic indicator in glioblastoma and may be a target of microRNA‑218
- (2019) Xuezhi Tong et al. Oncology Letters
- The promise of Immuno-oncology: implications for defining the value of cancer treatment
- (2019) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
- (2019) Erlend Skaga et al. BMC CANCER
- A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
- (2019) Patrick Y. Wen et al. CLINICAL CANCER RESEARCH
- CAR T cells for brain tumors: Lessons learned and road ahead
- (2019) David Akhavan et al. IMMUNOLOGICAL REVIEWS
- Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy
- (2019) Francesca Garofano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications
- (2019) Joshua D. Bernstock et al. JOURNAL OF NEUROSURGERY
- Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- (2018) Roberta Zappasodi et al. CANCER CELL
- Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor GrowthIn Vivo
- (2018) Robert A. Fenstermaker et al. CLINICAL CANCER RESEARCH
- Assessment of in vivo anti-tumor activity of human umbilical vein endothelial cell vaccines prepared by various antigen forms
- (2018) Ling Zhou et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Hitting the Target: How T Cells Detect and Eliminate Tumors
- (2018) Anthony E. Zamora et al. JOURNAL OF IMMUNOLOGY
- Cytokines in the Treatment of Cancer
- (2018) Kevin C. Conlon et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
- (2018) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial
- (2018) Marion Rapp et al. Trials
- Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8+ T cell responses
- (2018) Courtney S. Malo et al. Nature Communications
- Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
- (2018) Anna Wenger et al. NEOPLASIA
- Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
- (2018) Rimas V. Lukas et al. JOURNAL OF NEURO-ONCOLOGY
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
- (2018) Pakawat Chongsathidkiet et al. NATURE MEDICINE
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS
- (2018) Michael Platten et al. NEURO-ONCOLOGY
- Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System
- (2018) Ciro De Luca et al. Frontiers in Cellular Neuroscience
- T-cell exhaustion in glioblastoma
- (2018) Karolina Woroniecka et al. Oncotarget
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- OS09.8 Randomized placebo-controlled trial of autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
- (2017) Y. Muragaki et al. NEURO-ONCOLOGY
- Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
- (2017) Kevin Bielamowicz et al. NEURO-ONCOLOGY
- Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
- (2017) Antonio Omuro et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates
- (2017) Qiang Xue et al. Oncology Letters
- Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
- (2017) Jennifer P. Newman et al. Nature Communications
- Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
- (2017) Giedre Krenciute et al. Cancer Immunology Research
- The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer
- (2017) Jie Yin et al. Journal of Immunology Research
- History and current state of immunotherapy in glioma and brain metastasis
- (2017) Tresa McGranahan et al. Therapeutic Advances in Medical Oncology
- Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
- (2017) Abhishek D. Garg et al. OncoImmunology
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
- (2017) Thomas Powles et al. JAMA Oncology
- Remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy
- (2017) Xiao Zhao et al. Acta Pharmaceutica Sinica B
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Corticosteroids compromise survival in glioblastoma
- (2016) Kenneth L. Pitter et al. BRAIN
- Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma
- (2016) W. T. Curry et al. CLINICAL CANCER RESEARCH
- A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
- (2016) R. Rampling et al. CLINICAL CANCER RESEARCH
- Ipilimumab and Bevacizumab in Glioblastoma
- (2016) T. Carter et al. CLINICAL ONCOLOGY
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- The role of microglia and macrophages in glioma maintenance and progression
- (2016) Dolores Hambardzumyan et al. NATURE NEUROSCIENCE
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images
- (2016) Yi Cui et al. RADIOLOGY
- Myeloid-derived suppressor cells in gliomas
- (2016) Anna Gieryng et al. Wspolczesna Onkologia-Contemporary Oncology
- The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
- (2016) Caroline Jochems et al. Oncotarget
- Targeting immune checkpoints in malignant glioma
- (2016) Xuhao Zhang et al. Oncotarget
- Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
- (2016) Doo-Sik Kong et al. Oncotarget
- Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response
- (2015) Naoya Hashimoto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
- (2015) Stefano Ugel et al. JOURNAL OF CLINICAL INVESTIGATION
- Heat shock protein vaccines against glioblastoma: from bench to bedside
- (2015) Leonel Ampie et al. JOURNAL OF NEURO-ONCOLOGY
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
- (2015) Laura A. Johnson et al. Science Translational Medicine
- Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12
- (2015) Theofanis Floros et al. SEMINARS IN ONCOLOGY
- Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis
- (2015) Xi Feng et al. Oncotarget
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells
- (2014) S. K. Nair et al. CLINICAL CANCER RESEARCH
- Radiogenomics and Imaging Phenotypes in Glioblastoma: Novel Observations and Correlation with Molecular Characteristics
- (2014) Benjamin M. Ellingson Current Neurology and Neuroscience Reports
- Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers
- (2014) Yajing Zhang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma
- (2014) Julian Rauscher et al. JOURNAL OF CLINICAL PATHOLOGY
- Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
- (2014) B. Thaci et al. NEURO-ONCOLOGY
- The role of the immune system in central nervous system plasticity after acute injury
- (2014) L. Peruzzotti-Jametti et al. NEUROSCIENCE
- Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy
- (2014) Sadhak Sengupta et al. Biomed Research International
- Potential new gene therapy option with sitimagene ceradenovec for newly diagnosed patients with glioblastoma multiforme
- (2013) Timothy T Cavanagh et al. CANCER BIOLOGY & THERAPY
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- Brain dendritic cells: biology and pathology
- (2012) Paul M. D’Agostino et al. ACTA NEUROPATHOLOGICA
- Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
- (2012) Valérie Dutoit et al. BRAIN
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human umbilical vein endothelial cell vaccine therapy in patients with recurrent glioblastoma
- (2012) Minoru Tanaka et al. CANCER SCIENCE
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
- (2012) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
- (2012) C. A. Crane et al. CLINICAL CANCER RESEARCH
- Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors
- (2012) Giulia Mesiano et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The adaptive immune system in diseases of the central nervous system
- (2012) David C. Wraith et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF- 1 Signaling Pathway
- (2012) X.-z. Ye et al. JOURNAL OF IMMUNOLOGY
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- Consensus on the role of human cytomegalovirus in glioblastoma
- (2012) K. Dziurzynski et al. NEURO-ONCOLOGY
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
- (2011) Stuart A. Grossman et al. CLINICAL CANCER RESEARCH
- Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
- (2011) Camilo E. Fadul et al. JOURNAL OF IMMUNOTHERAPY
- Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma
- (2011) Yoshihiro Muragaki et al. JOURNAL OF NEUROSURGERY
- Significant Association of Multiple Human Cytomegalovirus Genomic Loci with Glioblastoma Multiforme Samples
- (2011) P. Ranganathan et al. JOURNAL OF VIROLOGY
- TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17
- (2011) Jiang ONCOLOGY REPORTS
- A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations
- (2011) X. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Extensive Invasive Intracranial Human Glioblastoma Xenograft Model
- (2010) Yunge Zhao et al. AMERICAN JOURNAL OF PATHOLOGY
- CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)
- (2010) Janka Held-Feindt et al. EXPERIMENTAL CELL RESEARCH
- Antigen presentation in EAE: role of microglia, macrophages and dendritic cells
- (2010) Beatriz Almolda Frontiers in Bioscience-Landmark
- T-cell exhaustion: characteristics, causes and conversion
- (2010) John S. Yi et al. IMMUNOLOGY
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation
- (2010) Kaoru Tamura et al. JOURNAL OF NEUROSURGERY
- IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas
- (2010) Bo Qiu et al. MOLECULAR BIOLOGY REPORTS
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
- (2009) M D Groves et al. BRITISH JOURNAL OF CANCER
- CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines
- (2009) A. M. McCord et al. CLINICAL CANCER RESEARCH
- The EGFRvIII variant in glioblastoma multiforme
- (2009) Hui K. Gan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced Cytotoxic Function of Effector CD8+ T Cells Is Responsible for Indoleamine 2,3-Dioxygenase-Dependent Immune Suppression
- (2009) H. Liu et al. JOURNAL OF IMMUNOLOGY
- IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
- (2009) B. Baban et al. JOURNAL OF IMMUNOLOGY
- EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
- (2009) et al. NEUROSURGERY
- The Role of Tregs in Glioma-Mediated Immunosuppression: Potential Target for Intervention
- (2009) William Humphries et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
- (2008) C. J. Wheeler et al. CANCER RESEARCH
- Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy
- (2008) Yurai Okaji et al. EUROPEAN JOURNAL OF CANCER
- Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers
- (2008) Dario Sangiolo et al. INTERNATIONAL IMMUNOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy
- (2008) Toshihiko Wakabayashi et al. JOURNAL OF GENE MEDICINE
- Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
- (2008) Jian Gang Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
- (2008) Shuichi Izumoto et al. JOURNAL OF NEUROSURGERY
- Cytomegalovirus Immunity after Vaccination with Autologous Glioblastoma Lysate
- (2008) Robert M. Prins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
- (2008) Maximilian Diehn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started